News

KeraVet Gel Study Shows Preference Over Traditional Collars

KeraVet Gel Study Shows Preference Over Traditional Collars

Clinical Study Reveals Pet Parents' Preference for KeraVet Gel

KeraVet Bio, Inc. has recently concluded a clinical study demonstrating that pet parents favor using KeraVet Gel over the traditional Elizabethan collar, commonly known as the cone. This clinical study followed a previous research initiative that highlighted the product's effectiveness, showing a notable reduction in licking behavior and improved healing outcomes for pets.

Study Overview and Findings

The clinical study involved 20 patients from a veterinary clinic, all of whom would normally require a cone for post-treatment care. In this study, pet parents were randomly assigned into two groups: one received the cone, while the other utilized KeraVet Gel. The findings were quite striking, with 80% of pet owners in the cone group opting for a change to KeraVet Gel after experiencing the disadvantages of the cone.

Furthermore, an impressive 86% of those who used KeraVet Gel reported positively on their pet's recovery. Participant feedback was overwhelmingly positive, with comments highlighting how the gel effectively prevented pets from licking their wounds, allowing for a quicker healing process. One pet owner remarked, "The gel kept my dog from licking her granuloma which allowed the area to start healing," showcasing the product's utility in real-world scenarios.

Veterinary Perspectives on KeraVet Gel

Veterinary clinicians involved in the study were also highly impressed with KeraVet Gel. They rated it a 4 out of 5 overall and expressed gratitude for having an alternative to the traditional cone. One clinician noted, "It really helped to have a second option for pet owners that didn't want an E-collar," indicating that this product may fill an important need among veterinary practitioners and pet owners alike.

KeraVet Gel's Impact on Pet Aftercare

Dr. Luke Burnett, Founder and CEO of KeraVet Bio, shared his insights, stating that the results from this study align perfectly with feedback the company has received since the product's launch. He affirmed that KeraVet Gel is not just a product but a solution with evidence supporting its efficacy in improving quality of life for both pets and their parents.

This innovative wound care solution by KeraVet Bio offers a scientific alternative for managing post-operative care without the stress often associated with using cones. By allowing pets to recover comfortably without the hindrance of an E-collar, KeraVet Gel stands out as a modern option in veterinary medicine.

About KeraVet Bio, Inc.

KeraVet Bio, Inc. specializes in developing advanced veterinary wound care products, with KeraVet Gel being their flagship offering. The company is headquartered in Winston-Salem, North Carolina, and focuses on utilizing keratin biomaterials to create cutting-edge therapeutic solutions for various veterinary needs. Their commitment to innovation is evident in their ongoing research and product development efforts.

Conclusion

Overall, the completion of this clinical study underscores the increasing recognition of KeraVet Gel as an effective alternative to traditional cones for pet aftercare. With ongoing developments and positive feedback from both pet parents and veterinary professionals, KeraVet Bio, Inc. is poised to continue making significant strides in the veterinary field.

Frequently Asked Questions

What is KeraVet Gel used for?

KeraVet Gel is a veterinary wound care product used to promote healing and prevent licking in pets following surgery or injury.

How does KeraVet Gel compare to traditional cones?

Unlike traditional cones, KeraVet Gel allows for better comfort and mobility for pets, while still effectively managing their wounds.

What were the key findings of the clinical study?

The study demonstrated that a significant majority of pet parents preferred KeraVet Gel to the cone, with 86% reporting positive healing outcomes.

Who conducts the studies for KeraVet Bio products?

KeraVet Bio collaborates with veterinary clinics and professionals to conduct controlled clinical studies on their products.

How can I learn more about KeraVet Bio, Inc.?

Further information about KeraVet Bio and its products can typically be found on their official website or by contacting their customer service.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Plan A Bets on AI in High-Stakes M&A Arena

Updated Category News Views 1

Digging Deeper with AI in M&A Deals Picture this: you’re at the table with a fat corporate M&A deal, eyes darting as you decipher numbers and nods, when out swings Plan A Technologies with their new ace up their sleeve—a stealth AI assessment tool armed to sharpen their technical due diligence. Unmasking the Tech Jigsaw Las Vegas-based Plan A Technologies hasn't just...

Continue Reading
Acer's New Monitors: ePaper, Triple Displays & More

Updated Category News Views 8

Next-Gen Screens: Breakthrough or Bust? So, Acer’s stepping up its game, unveiling an armory of gadgets designed to cement their spot in the tech arena. On the menu today? ePaper displays and enhanced connectivity gizmos that could either tip the scales or sink like a stone. Keep your eyes peeled, though—these updates aren't just another throwaway press release....

Continue Reading
UNISORB Expands Reach with BILZ Acquisition

Updated Category News Views 0

UNISORB Acquisition: A Game-Changer for Industrial Solutions This ain't the first time a company took over another to expand its footprint, but UNISORB's latest move to scoop up BILZ-USA is worth a closer look. Everybody's talking about this takeover that throws UNISORB right into the spotlight of North America's industrial sector. Naming them the exclusive distributor of...

Continue Reading
Tradr's Bold Venture: Anthropic ETFs Ahead of IPO

Updated Category News Views 2

Why Tradr Is Diving Into Anthropic's Hype There's a whiff of anticipation in the air as Anthropic gears up for its much-anticipated IPO, and Tradr isn't sitting on its hands here. They've just filed for two ETFs—one long, one short—ahead of the big day. We're talking about ANTT and ANTZ, betting on leveraged and inverse plays on whatever whirlwind Anthropic's stock...

Continue Reading
York Urged to Retire Research Macaques After Probe

Updated Category News Views 4

Undercover Investigation Shakes Up York University If you thought the world of research was all about sterile labs and the pursuit of knowledge, think again. The Jane Goodall Institute (JGI), famed for championing animal welfare, has urged York University to let go of nine long-suffering rhesus macaques. Turns out, these macaques weren't exactly living their best lives....

Continue Reading
Early Education's Massive Impact: Key Skills for Success

Updated Category News Views 2

Unlocking Lifelong Success: The Early Advantage Ever look at a successful adult and wonder, "Where'd they get that spark?" According to HelloNation and child care expert Karen Ego, it all starts early. Think of early learning not just as prepping for school, but as the first blueprint for life's journey. It's the skills you pick up in those tender years that stick it out...

Continue Reading
Backroads Sets 2027 Egypt Tour with Active Adventures

Updated Category News Views 1

Backroads Brings Adventure Travel to Egypt in 2027 There's an entirely fresh way to get your kicks by the pyramids, and it's coming straight from Backroads, the bigwig of active travel. They're rolling out a Multi-Adventure Tour in the heart of Egypt for 2027. It's got all the bells and whistles: hiking, biking, and kayaking, packaged with a side of luxury at posh hotels...

Continue Reading
Texas Institute Leads Trailblazing Arrhythmia Study

Updated Category News Views 2

Breaking New Ground in Heart Rhythm Treatment Well, here's a twist that even the stock market folks might envy—pioneering innovation in healthcare. This time, it’s not about tech stocks or a bull market, but about real human lives. The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center in Austin has jumped to the forefront by participating in a...

Continue Reading
Evotec and Plectonic Join Forces on Tumor Immunotherapy

Updated Category News Views 4

Collaboration Spotlight: A New Horizon for Tumor Treatments Ever wonder why curing solid tumors has been such a tough nut to crack? Evotec SE (NASDAQ: EVO) and Plectonic Biotech are wagering that their collaboration might just hold the key to unlocking new answers. They’re pooling their cutting-edge tech to take a fresh swing at this stubborn problem. Here’s what’s...

Continue Reading
Codoxo Snags 2026 Award for AI Payment Innovation

Updated Category News Views 1

Revolutionizing Healthcare Payment with AI Ah, healthcare and payments—two things that can make even the most patient folks lose their cool. But here comes Codoxo, shaking up this landscape with its Point Zero Payment Integrity solution, and someone's finally giving them the nod they deserve. For those of us who have been in the game for a while, this announcement is...

Continue Reading

Top 5 Most Recently Viewed Articles

The Future of Antigen and Antibody Diagnostics: A $68 Billion Vision

Updated Category News Views 125

Antigen and Antibody Diagnostics Market: Overview of Growth Trends The field of antigen and antibody diagnostics is experiencing unprecedented growth, fueled by innovations in technology and an increasing demand for effective disease detection solutions. The market was estimated at around $43 billion recently, and projections indicate it could soar to approximately $68...

Continue Reading
Columbus A/S Updates on Recent Share Buyback Program

Updated Category News Views 124

Columbus A/S: Overview of Current Share Buyback Program Columbus A/S has embarked on an exciting journey to enhance shareholder value through a systematic share buyback program. This initiative aims to repurchase shares for an impressive total of up to DKK 16 million, marking a significant investment in the company's future and commitment to its shareholders. Details of...

Continue Reading
Rithm Capital Corp. Announces Q4 2024 Dividend Declarations

Updated Category News Views 245

Rithm Capital Corp. Announces Fourth Quarter 2024 Dividends Rithm Capital Corp. (NYSE:RITM) has proudly declared both common and preferred stock dividends for the fourth quarter of 2024. The announcement was made by the Company’s Board of Directors, reflecting their continued commitment to return value to shareholders. Details of Common Stock Dividend The Board has...

Continue Reading
Introducing ISU Steadfast: A New Era in Insurance Networks

Updated Category News Views 1109

ISU Steadfast: A Blend of Strength and Experience ISU Insurance Agency Network has initiated a major transformation by rebranding itself as ISU Steadfast. This change signifies a unique moment where ISU's rich history merges with the global insights and expertise of Steadfast Group, enabling both organizations to leverage their strengths collaboratively. The Evolution of...

Continue Reading
Edelson Lechtzin Investigates Quantum Corp for Alleged Misconduct

Updated Category News Views 220

Edelson Lechtzin LLP Takes Action Against Quantum Corporation Edelson Lechtzin LLP has initiated an investigation concerning Quantum Corporation (NASDAQ: QMCO) related to possible breaches of federal securities laws. This investigation arises from concerns over allegations that the company might have shared misleading information regarding its business operations with...

Continue Reading